Charts
From 02/05/2022 our Markets Data content will no longer be free to read. To continue to get full access, subscribe now and receive 25% off.
Equities

Vericel Corp

Vericel Corp

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)59.11
  • Today's Change2.40 / 4.23%
  • Shares traded2.00
  • 1 Year change+66.55%
  • Beta1.7059
Data delayed at least 15 minutes, as of Nov 22 2024 21:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Key statistics

On Friday, Vericel Corp (VCEL:NMQ) closed at 59.11, -1.74% below its 52-week high of 60.16, set on Nov 22, 2024.
52-week range
Today
32.31Jan 08 202460.16Nov 22 2024
Short selling activity
Low
Med
High
Provided by S&P Global Market Intelligence
Open56.70
High60.16
Low56.52
Bid23.65
Offer93.98
Previous close56.71
Average volume472.21k
Shares outstanding49.36m
Free float48.90m
P/E (TTM)764.09
Market cap2.92bn USD
EPS (TTM)0.0774
USD
Data delayed at least 15 minutes, as of Nov 22 2024 21:00 GMT.
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
S&P Global Market Intelligence Short Selling Activity © S&P Global Market Intelligence. All rights reserved.
Although S&P Global Market Intelligence has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of S&P Global Market Intelligence on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.